Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
Abstract The prescribing of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has surged for the treatment of diabetes and obesity, with more than 15 million users worldwide
International Journal of Molecular Sciences , 22 (12), 6623
is supported by the MERIT Sawyers Fellowship
Clinical trial data in humans indicate that exenatide or liraglutide may have a role in the treatment of T2DM as monotherapy or in addition to oral antidiabetic drugs
US$ 25.52
US$ 27.80
US$ 20.29
US$ 27.34
